Overall, the BRC cases analyzed had larger numbers of CD34+ tumor stromal vessels per TMA core (mean 11; range 0–45) as compared to VEGFR2+ tumor stromal vessels per TMA core (mean 3.4; range 0–20). This evidence concerns the gene CD34 and neoplasm.